Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways

Prostate

Volumn 74, Issue 12, 2014, Pages 1189-1198

  Vaz, Cátia V ^a   Maia, Cláudio J ^a   Marques, Ricardo ^a   Gomes, Inês M ^a   Correia, Sara ^a   Alves, Marco G ^a   Cavaco, José E ^a   Oliveira, Pedro F ^a   Socorro, Sílvia ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

androgen; apoptosis; proliferation; prostate; regucalcin

Indexed keywords

ANDROGEN; ANDROSTANOLONE; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; OLIGONUCLEOTIDE; PROTEIN BAX; PROTEIN BCL 2; REGUCALCIN;

AMPLICON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MALE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE WEIGHT; RAT;

ANDROGEN; APOPTOSIS; PROLIFERATION; PROSTATE; REGUCALCIN;

ANDROGENS; ANIMALS; APOPTOSIS; CALCIUM-BINDING PROTEINS; CELL CYCLE; DOWN-REGULATION; GROWTH INHIBITORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84904658283     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22835     Document Type: Article

References (28)

1. Yamaguchi M, Yamamoto T,. Purification of calcium binding substance from soluble fraction of normal rat liver. Chem Pharm Bull (Tokyo) 1978; 26 (6): 1915-1918.
2. Maia C, Santos C, Schmitt F, Socorro S,. Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones. J Cell Biochem 2009; 107 (4): 667-676.
3. Laurentino SS, Correia S, Cavaco JE, Oliveira PF, Rato L, Sousa M, Barros A, Socorro S,. Regucalcin is broadly expressed in male reproductive tissues and is a new androgen-target gene in mammalian testis. Reproduction 2011; 142 (3): 447-456.
4. Laurentino SS, Correia S, Cavaco JE, Oliveira PF, de Sousa M, Barros A, Socorro S,. Regucalcin, a calcium-binding protein with a role in male reproduction ? Mol Hum Reprod 2012; 18 (4): 161-170.
5. Capiod T, Shuba Y, Skryma R, Prevarskaya N,. Calcium signalling and cancer cell growth. Subcell Biochem 2007; 45: 405-427.
6. Isbarn H, Pinthus JH, Marks LS, Montorsi F, Morales A, Morgentaler A, Schulman C,. Testosterone and prostate cancer: Revisiting old paradigms. Eur Urol 2009; 56 (1): 48-56.
7. Yamaguchi M, Morooka Y, Misawa H, Tsurusaki Y, Nakajima R,. Role of endogenous regucalcin in transgenic rats: Suppression of kidney cortex cytosolic protein phosphatase activity and enhancement of heart muscle microsomal Ca2+ ATPase activity. J Cell Biochem 2002; 86 (3): 520-529.
8. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD,. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004; 64 (6): 2270-2305.
9. Pfaffl M,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29 (9): e45.
10. Labrie C, Lessard J, Aicha SB, Savard MP, Pelletier M, Fournier A, Lavergne Ã, Calvo E,. Androgen-regulated transcription factor AIbZIP in prostate cancer. J Steroid Biochem Mol Biol 2008; 108 (3): 237-244.
11. Knobil E, Neill J,. Knobil and Neill's physiology of reproduction, 3rd edition. St. Louis: Academic Press; 2006.
12. Yeap BB, Krueger RG, Leedman PJ,. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 1999; 140 (7): 3282-3291.
13. Martinez HD, Hsiao JJ, Jasavala RJ, Hinkson IV, Eng JK, Wright ME,. Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells. Genes Cancer 2011; 2 (10): 956-978.
14. Lehmusvaara S, Erkkila T, Urbanucci A, Waltering K, Seppala J, Larjo A, Tuominen VJ, Isola J, Kujala P, Lahdesmaki H, Kaipia A, Tammela T, Visakorpi T,. Chemical castration and anti-androgens induce differential gene expression in prostate cancer. J Pathol 2012; 227 (3): 336-345.
15. Makino R, Yamaguchi M,. Expression of calcium-binding protein regucalcin mRNA in hepatoma cells. Mol Cell Biochem 1996; 155 (1): 85-90.
16. Zhou SF, Mo FR, Bin YH, Hou GQ, Xie XX, Luo GR,. Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma. Clin Biochem 2011; 44 (4): 331-336.
17. King KL, Cidlowski JA,. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998; 60: 601-617.
18. Yamaguchi M,. The anti-apoptotic effect of regucalcin is mediated through multisignaling pathways. Apoptosis 2013; 18: 1145-1153.
19. Marques R, Maia CJ, Vaz C, Correia S, Socorro S,. The diverse roles of calcium-binding protein regucalcin in cell biology: From tissue expression and signalling to disease. Cell Mol Life Sci 2013; 71 (1): 93-111.
20. Nakagawa T, Sawada N, Yamaguchi M,. Overexpression of regucalcin suppresses cell proliferation of cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med 2005; 16 (4): 637-643.
21. Yamaguchi M, Daimon Y,. Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: Involvement of intracellular signaling factors and cell cycle-related genes. J Cell Biochem 2005; 95 (6): 1169-1177.
22. Tsurusaki Y, Yamaguchi M,. Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem 2003; 90 (3): 619-626.
23. Lawen A,. Apoptosis-An introduction. Bioessays 2003; 25 (9): 888-896.
24. Vermeulen K, Van Bockstaele DR, Berneman ZN,. Apoptosis: Mechanisms and relevance in cancer. Ann Hematol 2005; 84 (10): 627-639.
25. Nakagawa T, Yamaguchi M,. Overexpression of regucalcin suppresses apoptotic cell death in cloned normal rat kidney proximal tubular epithelial NRK52E cells: Change in apoptosis-related gene expression. J Cell Biochem 2005; 96 (6): 1274-1285.
26. Matsuyama S, Kitamura T, Enomoto N, Fujita T, Ishigami A, Handa S, Maruyama N, Zheng D, Ikejima K, Takei Y,. Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells. Biochem Biophys Res Commun 2004; 321 (2): 386-390.
27. Dallaglio K, Marconi A, Pincelli C,. Survivin: A dual player in healthy and diseased skin. J Invest Dermatol 2012; 132 (1): 18-27.
28. Lamouille S, Derynck R,. Oncogene and tumour suppressor: The two faces of SnoN. EMBO J 2009; 28 (22): 3459-3460.